Latest BOLT reports update at 2024-05-14: 2024-Q1 ∙ 2023-Q4 ∙ 2023-Q1
  1. Home
  2. Stock quotes
  3. Stock Bolt Biotherapeutics
Bolt Biotherapeutics logo

Bolt Biotherapeutics BOLT

$ 1.12 0.9%
mail-toReport an Error

Country

 usaUSA

IPO year

 2021

Industry

 -

Stock Exchange

 NASDAQ GLOBAL

CEO

 -

Employees in the company

 -

Shares

 37.8 M

Market Cap[1]

 $ 42.3 M

EBITDA (LTM)

 $ -71.7 M

P/E (LTM)

 -

P/S (LTM)

 -

EPS (LTM)

 -

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.